NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer



New cancer study findings have been reported by scientists at University of Michigan



April 2nd, 2009

According to recent research published in the journal Proteomics Clinical Applications, "An analysis of phosphorylation changes that occur during cancer progression would provide insights into the molecular pathways responsible for a malignant phenotype. In this study we employed a novel coupling of 2-D liquid separations and protein microarray technology to reveal changes in phosphoprotein status between premalignant (ATI) and malignant (CA1a) cell lines derived from the human MCF10A breast cell lines. intact proteins were first separated according to their pi and hydrophobicities, then arrayed on SuperAmine glass slides."

"Phosphoproteins were detected using...


Source: Women's Health Weekly (2009-04-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login